Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision

Gollins, 2017, Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) - multidisciplinary management, Colorectal Dis, 19, 37, 10.1111/codi.13705 Rutten, 2008, Controversies of total mesorectal excision for rectal cancer in elderly patients, Lancet Oncol, 9, 494, 10.1016/S1470-2045(08)70129-3 Aquina, 2017, The impact of age on complications, survival, and cause of death following colon cancer surgery, Br J Cancer, 116, 389, 10.1038/bjc.2016.421 de Neree Tot Babberich, 2018, Achievements in colorectal cancer care during 8 years of auditing in the Netherlands, Eur J Surg Oncol, 44, 1361, 10.1016/j.ejso.2018.06.001 Sedrak, 2021, Older adult participation in cancer clinical trials: a systematic review of barriers and interventions, CA Cancer J Clin, 71, 78, 10.3322/caac.21638 Bach, 2021, Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study, Lancet Gastroenterol Hepatol, 6, 92, 10.1016/S2468-1253(20)30333-2 Spencer, 2021, The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study, Lancet Oncol, 22, 309, 10.1016/S1470-2045(20)30743-9 Bach, 2009, A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer, Br J Surg, 96, 280, 10.1002/bjs.6456 Whistance, 2009, Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer, Eur J Cancer, 45, 3017, 10.1016/j.ejca.2009.08.014 Aaronson, 1993, The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, J Natl Cancer Inst, 85, 365, 10.1093/jnci/85.5.365 Bakx, 2005, Development and validation of a colorectal functional outcome questionnaire, Int J Colorectal Dis, 20, 126, 10.1007/s00384-004-0638-9 Rabin, 2001, EQ-5D: a measure of health status from the EuroQol Group, Ann Med, 33, 337, 10.3109/07853890109002087 Fayers, 1999 Osoba, 1998, Interpreting the significance of changes in health-related quality-of-life scores, J Clin Oncol, 16, 139, 10.1200/JCO.1998.16.1.139 Dolan, 1997, Modeling valuations for EuroQol health states, Med Care, 35, 1095, 10.1097/00005650-199711000-00002 McNair, 2016, Core outcomes for colorectal cancer surgery: a consensus study, PLoS Med, 13, e1002071, 10.1371/journal.pmed.1002071 Soo, 2021, The Elderly Functional Index (ELFI), a patient-reported outcome measure of functional status in patients with cancer: a multicentre, prospective validation study, Lancet Healthy Longev, 2, e24, 10.1016/S2666-7568(20)30036-2 Carpenter, 2017, A probabilistic programming language, J Stat Softw, 76, 10.18637/jss.v076.i01 Bürkner, 2017, brms: an R package for Bayesian multilevel models using Stan, J Stat Softw, 80, 10.18637/jss.v080.i01 Bürkner, 2018, Advanced Bayesian multilevel modeling with the R package brms, R J, 10, 395, 10.32614/RJ-2018-017 Albert, 2019 Nolte, 2019, General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States, Eur J Cancer, 107, 153, 10.1016/j.ejca.2018.11.024 Szende, 2014, Cross-country analysis of EQ-5D data, 31 Coretti, 2014, The minimum clinically important difference for EQ-5D index: a critical review, Expert Rev Pharmacoecon Outcomes Res, 14, 221, 10.1586/14737167.2014.894462 Podda, 2021, World J Emerg Surg, 16, 35, 10.1186/s13017-021-00378-9 Manceau, 2012, Comparative outcomes of rectal cancer surgery between elderly and non-elderly patients: a systematic review, Lancet Oncol, 13, e525, 10.1016/S1470-2045(12)70378-9 Boakye, 2018, Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis, Cancer Treat Rev, 64, 30, 10.1016/j.ctrv.2018.02.003 Claassen, 2018, Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison, Br J Cancer, 119, 517, 10.1038/s41416-018-0215-6 Garcia-Aguilar, 2015, Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial, Lancet Oncol, 16, 1537, 10.1016/S1470-2045(15)00215-6 Rullier, 2020, Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial, Lancet Gastroenterol Hepatol, 5, 465, 10.1016/S2468-1253(19)30410-8 Stijns, 2019, Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study, JAMA Surg, 154, 47, 10.1001/jamasurg.2018.3752 Martens, 2016, Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer, J Natl Cancer Inst, 108, djw171, 10.1093/jnci/djw171 Ngan, 2012, Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04, J Clin Oncol, 30, 3827, 10.1200/JCO.2012.42.9597 Glynne-Jones, 2017, Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 28, iv22, 10.1093/annonc/mdx224 Erlandsson, 2017, Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial, Lancet Oncol, 18, 336, 10.1016/S1470-2045(17)30086-4 Glimelius, 2017, What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait?, Acta Oncol, 56, 1139, 10.1080/0284186X.2017.1344359 Smart, 2016, Multicentre study of short-course radiotherapy and transanal endoscopic microsurgery for early rectal cancer, Br J Surg, 103, 1069, 10.1002/bjs.10171 Bujko, 2017, The feasibility of short-course radiotherapy in a watch-and-wait policy for rectal cancer, Acta Oncol, 56, 1152, 10.1080/0284186X.2017.1327721 Arezzo, 2015, Results of neoadjuvant short-course radiation therapy followed by transanal endoscopic microsurgery for t1-t2 n0 extraperitoneal rectal cancer, Int J Radiat Oncol Biol Phys, 92, 299, 10.1016/j.ijrobp.2015.01.024 Cummings, 2019, Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?, J Gastrointest Oncol, 10, 357, 10.21037/jgo.2018.09.05 Fokas, 2021, International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer, Nat Rev Clin Oncol, 18, 805, 10.1038/s41571-021-00538-5 Perez, 2011, Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates, Dis Colon Rectum, 54, 545, 10.1007/DCR.0b013e3182083b84 Rullier, 2017, Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial, Lancet, 390, 469, 10.1016/S0140-6736(17)31056-5 Gérard, 2019, Planned organ preservation for early T2-3 rectal adenocarcinoma: a French, multicentre study, Eur J Cancer, 108, 1, 10.1016/j.ejca.2018.11.022 Appelt, 2015, High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study, Lancet Oncol, 16, 919, 10.1016/S1470-2045(15)00120-5 Rijkmans, 2018, Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study, Radiother Oncol, 126, 417, 10.1016/j.radonc.2017.12.023 Garant, 2022, MORPHEUS phase II-III study: a pre-planned interim safety analysis and preliminary results, Cancers (Basel), 14, 3665, 10.3390/cancers14153665 Bach, 2022, Colorectal Dis, 24, 639, 10.1111/codi.16056